LENZ Therapeutics operates within the competitive ophthalmic pharmaceutical and presbyopia treatment market, competing directly against other prominent biotechnology and pharmaceutical firms developing pharmacological vision correction drops. Its primary commercial competitors include companies like Orasis Pharmaceuticals (manufacturer of Qlosi) and AbbVie / Allergan (manufacturer of Vuity), both of which market alternative pupillary-modifying eye drops designed to treat age-related near-vision loss.